BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 25495404)

  • 1. Variant CJD. 18 years of research and surveillance.
    Diack AB; Head MW; McCutcheon S; Boyle A; Knight R; Ironside JW; Manson JC; Will RG
    Prion; 2014; 8(4):286-95. PubMed ID: 25495404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes.
    Takeuchi A; Kobayashi A; Ironside JW; Mohri S; Kitamoto T
    J Biol Chem; 2013 Jul; 288(30):21659-66. PubMed ID: 23792955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guinea Pig Prion Protein Supports Rapid Propagation of Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease Prions.
    Watts JC; Giles K; Saltzberg DJ; Dugger BN; Patel S; Oehler A; Bhardwaj S; Sali A; Prusiner SB
    J Virol; 2016 Nov; 90(21):9558-9569. PubMed ID: 27440899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman.
    Mead S; Joiner S; Desbruslais M; Beck JA; O'Donoghue M; Lantos P; Wadsworth JD; Collinge J
    Arch Neurol; 2007 Dec; 64(12):1780-4. PubMed ID: 18071044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP; Peckeu L; Haïk S
    Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.
    Mead S; Poulter M; Uphill J; Beck J; Whitfield J; Webb TE; Campbell T; Adamson G; Deriziotis P; Tabrizi SJ; Hummerich H; Verzilli C; Alpers MP; Whittaker JC; Collinge J
    Lancet Neurol; 2009 Jan; 8(1):57-66. PubMed ID: 19081515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
    Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental sheep BSE prions generate the vCJD phenotype when serially passaged in transgenic mice expressing human prion protein.
    Joiner S; Asante EA; Linehan JM; Brock L; Brandner S; Bellworthy SJ; Simmons MM; Hope J; Collinge J; Wadsworth JDF
    J Neurol Sci; 2018 Mar; 386():4-11. PubMed ID: 29406965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice.
    Asante EA; Linehan JM; Gowland I; Joiner S; Fox K; Cooper S; Osiguwa O; Gorry M; Welch J; Houghton R; Desbruslais M; Brandner S; Wadsworth JD; Collinge J
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10759-64. PubMed ID: 16809423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effect of Val
    Fernández-Borges N; Espinosa JC; Marín-Moreno A; Aguilar-Calvo P; Asante EA; Kitamoto T; Mohri S; Andréoletti O; Torres JM
    Emerg Infect Dis; 2017 Sep; 23(9):1522-1530. PubMed ID: 28820136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease.
    Ironside JW; Head MW
    Curr Top Microbiol Immunol; 2004; 284():133-59. PubMed ID: 15148991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein.
    Asante EA; Linehan JM; Desbruslais M; Joiner S; Gowland I; Wood AL; Welch J; Hill AF; Lloyd SE; Wadsworth JD; Collinge J
    EMBO J; 2002 Dec; 21(23):6358-66. PubMed ID: 12456643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease.
    Bishop MT; Diack AB; Ritchie DL; Ironside JW; Will RG; Manson JC
    Brain; 2013 Apr; 136(Pt 4):1139-45. PubMed ID: 23449776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant Creutzfeldt-Jakob disease: an update.
    Ironside JW
    Folia Neuropathol; 2012; 50(1):50-6. PubMed ID: 22505363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.
    Manuelidis L; Liu Y; Mullins B
    J Cell Biochem; 2009 Feb; 106(2):220-31. PubMed ID: 19097123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant Creutzfeldt-Jakob disease strain is identical in individuals of two PRNP codon 129 genotypes.
    Diack AB; Boyle A; Plinston C; Hunt E; Bishop MT; Will RG; Manson JC
    Brain; 2019 May; 142(5):1416-1428. PubMed ID: 30938429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism.
    Bishop MT; Pennington C; Heath CA; Will RG; Knight RS
    BMC Med Genet; 2009 Dec; 10():146. PubMed ID: 20035629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: part 2.
    Collee JG; Bradley R; Liberski PP
    Folia Neuropathol; 2006; 44(2):102-10. PubMed ID: 16823692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid.
    Barria MA; Lee A; Green AJ; Knight R; Head MW
    J Pathol Clin Res; 2018 Apr; 4(2):86-92. PubMed ID: 29665324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.